Evans D G R, Maher E R, Baser M E
University Department of Medical Genetics, St. Mary's Hospital, Manchester M13 0JH, UK.
J Med Genet. 2005 Aug;42(8):630-2. doi: 10.1136/jmg.2004.027953.
It has been suggested that somatic mutations that accumulate due to an age related decline in the efficiency of DNA repair mechanisms might contribute to the increased incidence of cancer in older people. However, there is little direct evidence for this phenomenon. The spectra of germline and somatic mutations can be compared in cancer genes that cause inherited tumour syndromes and sporadic tumours, respectively. In addition, mosaic patients reflect the nature of mutations that occur in early development. Hence, we hypothesised that the "temporal mutation record" of a human cancer gene might provide insight into mechanisms of mutagenesis in the germline, in early development, and in adulthood. We compared the ratio of frameshift to nonsense mutations in three diseases that are related to the NF2 tumour suppressor gene: classic neurofibromatosis 2 (NF2), caused by germline NF2 mutations; mosaic NF2; and unilateral sporadic vestibular schwannoma (USVS), caused by somatic NF2 inactivation. Nonsense mutations predominated in both classic and mosaic NF2, but the ratio of nonsense to frameshift mutations was reversed in USVS. Moreover, in USVS patients, the ratio of somatic frameshift to nonsense mutations increased significantly with increasing age at diagnosis. This pattern is consistent with an age related decline in the efficiency of DNA repair mechanisms. Similar studies for other familial cancer genes may provide further evidence for this hypothesis.
有人提出,由于与年龄相关的DNA修复机制效率下降而积累的体细胞突变,可能是导致老年人癌症发病率增加的原因之一。然而,几乎没有直接证据支持这一现象。分别导致遗传性肿瘤综合征和散发性肿瘤的癌症基因中的种系突变和体细胞突变谱可以进行比较。此外,嵌合体患者反映了早期发育中发生的突变的性质。因此,我们推测人类癌症基因的“时间突变记录”可能有助于深入了解种系、早期发育和成年期的诱变机制。我们比较了与NF2肿瘤抑制基因相关的三种疾病中的移码突变与无义突变的比例:由种系NF2突变引起的典型神经纤维瘤病2型(NF2);嵌合型NF2;以及由体细胞NF2失活引起的单侧散发性前庭神经鞘瘤(USVS)。在典型和嵌合型NF2中,无义突变占主导地位,但在USVS中,无义突变与移码突变的比例则相反。此外,在USVS患者中,体细胞移码突变与无义突变的比例随着诊断年龄的增加而显著增加。这种模式与DNA修复机制效率随年龄下降一致。对其他家族性癌症基因进行类似研究可能会为这一假说提供进一步证据。